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ABSTRACT
Cardiovascular disease (CVD) is one of the major non-communicable diseases causing cardiac dysfunction and heart 
failure. In Malaysia, hypercholesterolemia or high blood cholesterol is known as CVD’s main risk factor. Currently, there 
is a paradigm shift of interest in Eastern medicines as alternative prevention approaches and therapeutic cholesterol 
control treatment. Ficus deltoidea (Mas Cotek) is amongst the eastern medicinal plants traditionally consumed either as 
prevention or treatment for various diseases such as hypertension, diabetes and hypercholesterolemia. This study utilised 
the proteomic application in determining the changes in a series of proteins that are being differentially expressed in 
response to F. deltoidea treatment of hypercholesterolemic-induced rats. Identification and quantification of proteins were 
conducted by using quantitative techniques, wherein two dimensional gel electrophoresis (2D-GE) along with Progenesis 
Samespots image analysis software and Matrix-assisted laser desorption/ionization Time-of-flight/Time-of-flight (MALDI 
ToF/ToF) mass spectrometry were utilised. Our results demonstrated that 14 protein spots had displayed alteration 
in their abundance at a minimum of 1.5 fold. Majority of these identified proteins were involved in lipid metabolism 
and immune system processes. These variables include apolipoprotein A1 (Apo A1), apolipoprotein E (Apo E), retinol 
binding protein 4 (RBP4), haptoglobin (HP), complement factor C3 (C3), complement factor C1s (C1s), transthyretin 
(TTR), ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3), prominin 1(PROM1) and plasminogen (PLG). 
Serum proteome analysis has unravelled the understanding on the mechanism of cholesterol reducing by F. deltoidea 
via augmentation of cholesterol biosynthesis that enhanced bile acids excretion, causing lowered cholesterol absorption 
in hypercholesterolemic rats.
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ABSTRAK
Penyakit kardiovaskular (CVD) adalah sejenis penyakit tidak berjangkit paling utama yang menyebabkan disfungsi 
kardiak dan kegagalan fungsi jantung. Di Malaysia, hiperkolesterolemia atau kandungan kolesterol yang tinggi 
di dalam darah merupakan faktor risiko umum penyakit kardiovaskular. Kini, perubatan alternatif timur semakin 
diterima sebagai rawatan pencegahan dan terapeutik untuk mengawal paras kolesterol darah. Ficus deltoidea 
(Mas Cotek) adalah antara tumbuhan yang digunakan di dalam perubatan tradisi timur bagi tujuan pencegahan 
atau rawatan penyakit tekanan darah tinggi, kencing manis dan kolesterol darah tinggi. Kajian ini menggunakan 
aplikasi kaedah proteomik untuk mengenal pasti protein yang menunjukkan perubahan ketara berikutan rawatan F. 
deltoidea ke atas tikus hiperkolesterolemik. Pengenalpastian dan pengkuantitian protein telah dijalankan dengan 
menggunakan teknik kuantitatif relatif seperti 2D-GE dengan bantuan perisian analisis imej Progenesis Samespots 
dan analisis spektrometer jisim MALDI ToF/ToF. Kajian kami menunjukkan terdapat 14 titik protein yang 
menunjukkan perubahan ketara sekurang-kurangnya 1.5 kali ganda. Kebanyakan protein yang dikenal pasti  terlibat 
dalam metabolisma dan pengangkutan lipid serta tindak balas radang dan imun. Ini termasuklah apolipoprotein 
A1 (Apo A1), apolipoprotein E (Apo E), retinol binding protein 4 (RBP4), haptoglobin (HP), complement factor 
C3 (C3), complement factor C1s (C1s), transthyretin (TTR), ectonucleotide pyrophosphatase/phosphodiesterase 3 
(ENPP3), prominin 1(PROM1) dan plasminogen (PLG). Penemuan protein-protein ini memberikan maklumat baru 
dalam pemahaman tindak balas molekul terhadap mekanisme yang terlibat dalam penurunan kolesterol berikutan 
rawatan F. deltoidea melalui biosintesis kolesterol yang meningkatkan penguraian asid hempedu sekaligus 
menurunkan penyerapan kolesterol di dalam tikus hiperkolesterolemik.
Kata kunci: 2D-GE; Ficus deltoidea; hiperkolesterolemia; perbezaan tahap pengekspresan; spektrometer jisim MALDI 
ToF/ToF 
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INTRODUCTION
Hypercholesterolemia (also known as dyslipidemia or 
high blood cholesterol) had been well known as the major 
risk factor contributing to worldwide cardiovascular 
disease (CVD) in this era (Wong 2014). The increased 
level of either cholesterol or low density lipoprotein 
(LDL) is mainly a progressive indicator of atherosclerotic 
lesions (Harrison et al. 2003). These lipid buildups 
within the coronary arteries are mostly macrophages 
transformed monocytes that engulf oxidised-LDL to 
develop foam cells or fat laden macrophages (Moore 
& Tabas 2011). The common risk factors for the 
development and aggravation of atherosclerotic include 
hypercholesterolemia, hypertension, smoking, and 
diabetes mellitus; with or without a family history, and 
this is related to pathophysiological vascular phenotype 
(Leopold & Loscalzo 2009). However, Hansson and 
Libby (2006) had emphasised the substantial role of 
hypercholesterolemia of which it is in complementary 
with immune mechanisms in the pathogenesis of 
atherosclerosis. In order to prevent future increment of 
CVD, there is a need to tackle new challenges through 
the enormous continuous involvement of research and 
development efforts.
Statins or 3-hydroxy-3-methylglutaryl-coenzyme A 
(HMG Co-A) reductase inhibitor is a common synthetic 
cholesterol lowering drug used for hypercholesterolemia 
treatment (Ministry of Health Malaysia 2017). Besides 
lowering the cholesterol levels, statins inherit pleiotropic 
effects which include improving endothelial function, 
stabilising the atherosclerotic plaque, prevention of 
oxidative stress by reducing inflammation rate and cell 
damages through oxidation, and to prevent thrombosis.
Herbal medicine popularity had emerged in various 
countries as an alternative option to treat CVDs and 
other chronic diseases, such as hypertension and diabetic 
(Alwi et al. 2018; Tachjian et al. 2010; Thong-asa et 
al. 2019). F. deltoidea has been used as an alternative 
traditional medicine in some Asian countries (Mat et al. 
2012) as it is deemed to have pharmacological properties 
in reducing high cholesterol level (Kalman et al. 2013). 
Currently, several scientific studies had shown that F. 
deltoidea potentials as antidiabetic (Misbah et al. 2013), 
anti-hypertensive (Razali et al. 2013), antinociceptive 
(Sulaiman et al. 2008), anti-inflammatory (Abdullah 
et al. 2009), antimelanogenic (Oh et al. 2011), and 
antiphotoageing (Hasham et al. 2013). This plant has also 
the ability to assist in uterine contraction (Ibrahim et al. 
2018) as it possessed antioxidant activities (Hakiman & 
Maziah 2009). It has also been reported to be a highly 
potential element to lessen the risk of CVD by reducing 
total cholesterol, LDL-cholesterol and atherogenic index 
(LDL/HDL ratio) as well as increasing the percentage of 
HDL/total cholesterol ratio (Hadijah et al. 2004).
Proteomics is the study of proteomes and its 
specific functions; an approach that had been widely 
used to analyse protein expression in blood serum, 
tissues, cells and body fluids (Parekh 1999). Apart from 
the identification of major proteins in the sample of 
interest; alteration in protein expression could also be 
detected in order to distinguish between healthy and 
unhealthy tissue/sample. However, there has been no 
extensive proteomic study carried out on serum from 
hypercholesterolemic rats treated with F. deltoidea. Thus, 
this current study aims to characterise the alteration in 
serum proteome in response to F. deltoidea treatment in 
hypercholesterolemic animals using relative quantitative 
proteomics techniques.
MATERIALS AND METHODS 
CHEMICALS AND REAGENTS
All chemicals were obtained from Sigma Aldrich (St. 
Louis, MO) unless otherwise specified. Commercialised 
statin drug (Atorvastatin) was purchased from a 
registered pharmacy. IPG strips, urea, CHAPS, were 
obtained from GE Healthcare Bio-Sciences (Piscataway, 
NJ, USA). Acrylamide, bisacrylamide, TEMED, DTT, 
and other reagents for electrophoresis as well as silver 
nitrate were purchased from Merck Limited (Hercules, 
CA, USA). Sequencing grade trypsin was procured from 
Promega Corporation (Madison, WI, USA). Western Blot 
diaminobenzidine (DAB) substrate detection kit was 
obtained from Nacalai Tesque (Kyoto, Japan) whereas 
all antibodies (Primary antibody: chicken polyclonal 
antibody to haptoglobin, mouse monoclonal antibody to 
RBP4; secondary antibody: rabbit polyclonal antibody 
to chicken antibody, rabbit polyclonal antibody to 
mouse antibody) were purchased from Abcam Ltd. 
(Cambridge, UK).
PREPARATION AND EXTRACTION OF Ficus deltoidea 
LEAVES
The leaves of Ficus deltoidea var kunstleri were 
harvested from a plantation in Rembau, Negeri 
Sembilan, Malaysia. A voucher specimen (KLU 
046470) was obtained from the Herbarium, Rimba 
Ilmu, University of Malaya. The leaves were air-dried 
before being grounded into a fine mesh. Extraction was 
conducted with 90% ethanol using a soxhlet apparatus 
(Favorit, Malaysia). The solvent was evaporated under 
vacuum using rotary evaporator (BUCHI Rotavapor 
R-114, Switzerland) and the resulting ethanolic 
extract (EE) was then stored in tight-capped containers 
at room temperature until further use.
EXPERIMENTAL ANIMALS AND 
HYPERCHOLESTEROLEMIA INDUCTION
Albino Wistar-Kyoto-Rats (WKY) rats weighed 120-150 
g were purchased from the Animal House, University of 
Sains Malaysia (USM). All methods and procedures used 
in this study experiments were approved standard by the 
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University of Malaya - Institutional Animal Care and Use 
Committee (ISB/25/04/2013/NA(R). The animals were 
acclimatised under standard laboratory conditions and 
within normal photoperiod (12 h light: 12 h dark cycle) 
for two weeks. They were being fed with commercial 
rat pellets and tap water, ad libitum wise. At the end of 
the acclimatisation period, the animals were randomly 
divided into five groups of six animal numbers (n=6) 
each. 
Group 1 served as the control group (C) 
which received normal diet and water. The other 4 
groups (Group 2-5) of rats were being subjected to 
hypercholesterolemic state induction; the rats were fed 
with a high fat diet (a mixture containing roasted Bengal 
flour, groundnut flour, milk powder, health mix and 
butter) as a routine daily diet for a period of 30 days. Rats 
had free access to normal tap water for drinking. Wherein 
the cholesterol-induction state, the rats were given 
different doses of EE and drugs through oral gavage. 
Normal rats received only distilled water. Group 2 (HC) 
served as hypercholesterolemic control or diseased state, 
received distilled water; group 3 (HC-E50) received 50 
mg/kg body weight of EE; group 4 (HC-E250) received 
250 mg/kg body weight of EE and group 5 (HC-Ato) 
received Atorvastatin (10 mg/kg body weight) once 
daily for a period of 21 days. The rats were then sacrificed 
by CO2 asphyxiation and bloods were immediately 
collected through an incision made in the jugular vein. 
Serum samples were obtained by centrifugation at 5000 
rpm for 5 min and stored at -80 oC until analysis. The 
serum lipid profile analysis was later being outsourced 
to Clinical Diagnostic Laboratory (CDL), University of 
Malaya Medical Centre. 
TWO DIMENSIONAL GEL ELECTROPHORESIS (2D-GE)
An amount of 80 ug protein was loaded to a 24 cm 
nonlinear pH 4-7 immobiline linear gradient dry strip. 
The serum proteins were resolved accordingly to their 
pIs using the Ettan IPGphor3 system (GE Healthcare) 
with the following method set-up - Step 1 [Step and 
hold]: 500 V for 1 h; Step 2 [Gradient]: 1000 V for 7 h; 
Step 3 [Gradient]: 8000 V for 3 h and Step 4 [Step and 
hold]: 8000V for 7 h 30 min. The focused IPG strips 
were reduced, alkylated and subjected to SDS-PAGE using 
linear 11% polyacrylamide gels run on Ettan DALT Six 
(GE Healthcare) at 80V for 1 h and 500V for 7 h at 25 oC.
STAINING AND IMAGING OF 2D-GE GELS
The gels were fixed overnight prior to silver staining 
according to the method done by Yan et al. (2000). 
Subsequently, image analyses were performed using 
Progenesis Software (Non Linear Dynamics, Newcastle 
Upon Tyne, Tyne & Wear, UK). The proteome profiles of 
all tested groups were then compared with the proteome 
of the normal group. The aligned images were grouped 
into their respective treatment group and evaluated 
statistically in the review step using ANOVA p-value.
PREPARATION OF SAMPLE FOR MASS SPECTROMETRY 
ANALYSIS
Silver stained spots that showed significant alteration in 
their abundance were excised manually, and gel plugs 
were later subjected to digestion procedure. Prior to 
digestion; the gel plugs were distained twice with 15 mM 
potassium ferricyanide in a 50 mM sodium thiosulphate, 
reduced using 10 mM DTT in 100 mM ammonium 
bicarbonate; and alkylated using 55 mM iodoacetamide 
in 100 mM ammonium bicarbonate. The gel plugs 
were dehydrated with 50% and 100% acetonitrile, 
respectively, and were dried in the speed vacuum. The 
in-gel digestion with sequencing grade trypsin (7 ng/
uL) (PROMEGA) in 40 mM ammonium bicarbonate was 
carried out by overnight incubation at 37 oC.
PROTEIN IDENTIFICATION BY USING MALDI TOF/TOF MS 
ANALYSIS
Following digestion procedures, proteins were extracted 
from the digested gel plugs using acetonitrile. Dried 
extracted protein samples were then prepared to clean-
up step using C18 ZiptipTM (Millipore, Bedford, MA). An 
equivalent volume of eluted samples and matrix (6 mg/
mL α- cyano-4-hydroxy-transcinnamic acid) were mixed 
and transferred onto MALDI ToF/ToF sample plate 
(384 Opti-TOF 123 × 81 mm, ABSciex). The samples 
were allowed to air dry and then analysed using ABI 
4800 MALDI ToF/ToF Plus (Applied Biosystems, Foster 
City, USA) mass spectrometer. The MS along with MS/
MS spectra were matched with the theoretical peptide 
masses using the Mascot™ database search engine 
v2.2.03 (Matrix Science Ltd., London, UK) and searched 
against SwissProt 51.6 database with the following 
setups: Trypsin cleavage; allowed one missed cleavage; 
fixed modification: carboxymethylation of cysteine (C); 
variable modification: oxidation of methionin (M); MS 
precursor mass tolerance was set to ±100 ppm, mass 
tolerance set at ±0.2 Da. and monoisotopic with MH+ 
mass value. The unmatched peptides were analysed 
using Profound software accessible online: http://prowl.
rockefeller.edu/prowl-cgi/profound.exe with Rattus as 
taxonomy category; mass range of 0 to 100 kDa; protein 
pI in between 4 and 7; allowed one missed cleavage and 
MH+ charge state with mass tolerance of 0.5 to 1.15 Da. 
NETWORK ANALYSIS
Functional analysis of the differential expressed proteins 
were carried out using Ingenuity Pathway Analysis (IPA) 
software (Ingenuity Systems, http://www.ingenuity.
com/) to generate a predicted network based on different 
biofunctions. At least 10 identified protein details and 
quantitative fold expressed were imported into IPA 
software for pathway and functional analysis. The 
networks were scored accordingly by IPA based to the 
significance of the proteins (calculated p-value) in the 
network using right tailed Fisher’s exact test.
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VALIDATION OF DIFFERENTIALLY ALTERED PROTEINS 
BY WESTERN IMMUNOBLOT ANALYSIS
Serum samples were reduced by 2-mercaptoethanol 
prior to loading onto the wells of 4% stacking gel and 
12.5% SDS-PAGE. Electrophoresis was conducted at 60 
mA and later increased to 120 mA once it reached the 
separating gel phase. Proteins were transferred onto 
nitrocellulose membranes under semi-dry conditions 
by using Trans-Blot® SD Semi-Dry electrophoretic 
transfer cell (Biorad, USA). The membranes were first 
blocked with 5% non- fat milk in TBS/0.1%Tween-20 
(TBST) overnight at 4 oC (HP) and 1 h at room temperature 
(RBP4). The membranes were consequently washed 
twice with fresh TBST for 5 and 10 min, respectively. 
Antibody solutions were prepared using 5% non-
fat milk in TBST: For detection of HP, the antibody 
binding procedure involved overnight incubation at 4 
oC with the primary chicken anti-haptoglobin antibody 
(1:1000 dilution, Abcam, Cambridge, UK), followed 
by horseradish peroxidase (HRP)-conjugated secondary 
antibody (1:10000 dilution rabbit anti-chicken, Abcam, 
Cambridge, UK) incubation for two hours at room 
temperature. For detection of RBP4, membrane was 
probed for one hour at room temperature with primary 
rabbit anti-RBP4 antibody (1:200 dilution, Abcam, 
Cambridge, UK) and then incubated at room temperature 
for two hours with secondary antibody (1:1000 dilution 
rabbit anti mouse, Abcam, Cambridge, UK). Bands 
on the membrane were developed with a substrate, 
3,3’-diaminobenzidine (DAB Nacalai Tesque, Kyoto, 
Japan) consolidated with the metal enhancer for DAB 
stain in the presence of hydrogen peroxide. The intensity 
of both HP and RBP4 bands were visually compared 
against the loaded protein ladder with molecular weight 
markers range from 11 to 245 kDa.
RESULTS
SERUM LIPID PROFILE ANALYSIS
Rats serum lipid profiling (Table 1) showed an obvious 
difference in the profile between healthy and disease-
state groups. Hypercholesterolemic-induced group (HC) 
demonstrated an increase in all the observed parameters; 
triglycerides and total cholesterol levels were significantly 
increased by 61.5% and 52%, respectively, while HDL 
was increased by 25.2% compared to the control. The 
increment in LDL was also seen as it appeared to reach 
the detectable value as oppose to the controlled rate. 
Treatment with atorvastatin demonstrated normalising 
effects whereby all observed parameters were lowered 
compared to HC. A similarly reduced trend was also 
observed following the administration of Ficus sample, 
HC-E50 and HC-E250 compared to HC with an exception 
to the increase in HDL level in the HC-E250 treated 
sample. Treatment with HC-E50 appeared to exhibit a 
better normalising effect compared to HC-E250.
TABLE 1. Serum lipid profile of hypercholesterolemic-induced rats
Group
Lipid parameters (10-2 µmol/l)
TG TC HDL LDL
C 0.59 ± 0.08 3.78 ± 0.13 3.49 ± 0.16 ND
HC 0.95 ± 0.21* 5.74 ± 0.48* 4.37 ± 0.13 0.16 ± 0.10
HC-E50 0.57 ± 0.14** 4.53 ± 0.33 3.93 ± 0.23 0.05 ± 0.05
HC-E250 0.70 ± 0.16 5.28 ± 0.18 4.55 ± 0.14 0.13 ± 0.08
HC-Ato 0.57 ± 0.07 4.40 ± 0.39 4.03 ± 0.32 ND
Values are mean ± SD. * indicates statistical significance against C (p<0.05). **indicates statistical significance against HC (p<0.05)
TG: Triglycerides, TC: Total cholesterol, HDL: High density lipoproteins, LDL: Low density lipoproteins, ND: Not detected, below 
threshold level, C: Control/normal rats, HC: hypercholesterolemic-induced rats, HC-E50: hypercholesterolemic-induced with Ficus-treated 
rats (50 mg/kg EE), HC-E250: hypercholesterolemic-induced with Ficus-treated rats (250 mg/kg EE), HC-Ato: hypercholesterolemic-
induced with atorvastatin-treated rats, Units are in micromol per liter (µmol/l) 
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2D-GE PROTEOMICS ANALYSIS
2D-GE analysis of serum proteomes from treated and non-
treated hypercholesterolemic- induced rats were 
performed. Nearly 1000 individual spots ranging from 
7 to 210 kDa with pI between 4 and 7 were discovered 
using Progenesis Samespots software. We observed 
27 protein spots that were significantly different with 
p values less than 0.05 (ANOVA) when compared with 
those in controlled (normal) groups. Based on MALDI 
ToF/ToF MS data search, ten spots were matched with 
known proteins in MASCOT database and four other 
protein spots with low MOWSE score from this search 
were re-analysed using the Profound software, using 
data of the non-matched peptides. A significant Z-score 
(Est’d Z) of 2.43 with a high probability of 1.0e+000 
denotes 99.5% confidence level with only 0.5% false 
positive. The identified proteins were presented in the 
2D-GE maps of master gel visualised by silver staining 
(Figure 1). The names of the identified proteins and their 
respective abbreviations are listed in Table 2.
These significantly altered proteins were mainly 
associated with lipid metabolism and transport, 
inflammation and immune response, anti-oxidant 
protein, acute phase protein, cholesterol homeostasis 
and cholesterol binding. Other identified proteins were 
involved in pheromone binding and coagulation. Based 
on the past literature research, the categorised functions 
of these proteins are depicted in Figure 2.
Comparative analysis of spot abundancy pattern 
of each identified protein is shown in Figure 3. HC 
or diseased state rats demonstrated an increased in 
abundance of C3, ENPP3, C1s, CPI, RBP4, PROM1, Apo 
E, HP, PLG and decreased in abundance for TTR, MUP 
and Apo A1. Atorvastatin (Ato), the common cholesterol 
lowering drug demonstrated distinguished increase of 
Apo A1, TTR, CPI and HP but decreased abundance of 
Apo E, PROM1, RBP4, PLG, MUP, C1s and C3 when 
compared to HC. With comparison to HC, treatment with 
higher dosage of F. deltoidea extract (250 mg/kg, HC-
E250) markedly induced increment of Apo A1, CPI and 
HP; and decrease of ENPP3, C3, TTR, Apo E, C1s, PROM1, 
MUP, PLG and near normalisation of RBP4. However, 
treatment with low dosage of F. deltoidea extract (50 
mg/kg, HC-E50), nearly normalised the TTR level in 
hypercholesterolemic-induced rats. Other proteins like 
CPI, PROM1, RBP4 and PLG demonstrated similar pattern 
as observed in HC-E250. However, HP and C3 exhibited 
spots with greater intensities when compared to HC-E250.
FIGURE 1. A representative 2D-GE gel of serum proteins from hypercholesteromic-induced 
rats.2D-GE was performed using 80 ug of protein sample loaded onto an IPG strip (pH range 
4-7) and subsequently separated on 11% SDS-PAGE
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TABLE 2. List of significantly altered proteins identified by MALDI ToF/ToF
Spot ID
Protein Identification
Acc 
number/ 
SWISS 
PROT
MASCOTa
Profound 
(Est’d Z 
score)
Sequence 
coverage 
(%)
Theoretical Observed
Mascot 
score
Matched 
peptide
Mw 
(kDa)
pI
Mw 
(kDa)
pI
A. Mascot Database search : http://www.matrixscience.com
1652 Complement C3 precursor (C3) P01026 60 21 / 85 24.7 186.5 6.1 35 5.4
1998
Contrapsin-like protease inhibitor 1 
precursor (CPI)
P05545 75 2 / 18 11.1 44.6 5.3 46.8 5.3
2690 Apolipoprotein A1(Apo A1) P04639 25 5 / 40 12.5 27.4 5.5 13 6.5
2803
Retinol binding protein 4 precursor 
(RBP4)
P04916 242 10 / 72 13.8 21.4 6 14 6.2
3046 Major urinary protein (MUP) P02761 71 7 / 104 6.7 17.6 5.4 11 5.5
3434 Haptoglobin (HP) P06866 108 2 / 2 100 36.6 6 8 4.9
3485 Transthyretin (TTR) P02767 30 6 / 70 8.6 13.6 5.8 7.1 5.6
4262 Plasminogen (PLG) Q01177 29 2 / 16 12.5 88.3 6.8 14 5.1
4643 Apolipoprotein E (Apo E) Q6PAH0 259 19 / 35 54.0 33.8 5.2 29 5.0
2095 Complement C1s (C1s) Q6P6T1 45 3 / 24 7.1 75.3 4.7 28 5.9
B. Profound Database search : http://prowl.rockefeller.edu/prowl-cgi/profound.exe
1857
Prominin-1 isoform 2 precursor 
(PROM1)
Q7TSL4 2.43 14.0 93.2 6.1 31 4.9
3023
Ectonucleotide pyrophosphatase/
phosphodiesterase 3
(ENPP3)
P97675 2.43 14.0 99.2 5.9 90 5.9
2682
Islet cell autoantigen 1-like protein 
(Ica1l)
Q6RUG5 2.43 35.0 48.6 5.2 15 4.6
1940
Ectoderm-neural cortex protein 2 
(ENC2)
Q4KLM4 2.07 22.0 65.8 6.3 31 4.5
a denotes Mascot probability based molecular weight search score calculated for PMF. Protein score is -10 × log [P], where P is the probability that the observed match is 
a random event. The scores are based to Swiss-Prot database using the MASCOT searching program in MS/MS spectra
*Z-Score estimation corresponds with the percentile of the search with significant certainty: Z score 1.282 = 90%; 1.645 = 95%; 2.326 = 99%;
3.09 = 99.9% confidence
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A - data search using MASCOT database. The identified proteins were displayed horizontally with respective categorised functions.(a) 
Inflammation and immune response; (b) Lipid metabolism and transport; (c) Anti-oxidant protein; (d) Coagulation/fibrinolysis; (e) Acute phase protein; 
(f) Pheromone binding; (g) Cholesterol homeostasis
B - data search using Profound. Identified proteins were displayed horizontally with categorised functions (a) Cholesterol binding; (b) Inflammation 
and immune response; (c) unknown
FIGURE 3. Protein spots differential abundancy patterns for treated and non-treated hypercholesterolemic-
induced rats. Magnified spots of 2D-GE images represent differential abundancy patterns between the different rat 
groups
FIGURE 2. Categorised functions of identified proteins acquired by data search
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signaling being ranked the highest significance of p < 
8.28 × 1013in a canonical pathway analysis as tabulated 
in Table 3. Figure 4 shows an interactive IPA predicted 
network analysis between Apo A1, Apo E, RBP4, HP, 
ENPP3, C3, C1s, PROM1, TTR and PLG. However, the 
other two putative proteins, CPI and MUP were not linked 
in the network analysis.
NETWORK ANALYSIS
The biological functions of the proteins identified were 
further investigated using Ingenuity Pathway Analysis 
(IPA) software. The altered proteins subjected to IPA 
analysis generated network with highest score of 25 
on ‘Lipid Metabolism, Molecular Transport, Small 
Molecule Biochemistry’ with acute phase response 
TABLE 3. Top network and canonical pathway generated by Ingenuity Pathway Analysis (IPA) software
Associated network functions Scorea
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry 25
Cardiovascular System Development and Function, Cellular Development, 
Cellular Function and Maintenance 3
Top canonical pathway P-value
Acute Phase Response Signaling 8.28E-13
Atherosclerosis Signaling 3.48E-05
a 
A score of 2 or higher indicate at least 99% confidence of not being generated by random chance and higher scores indicate a greater
confidence
FIGURE 4. IPA generated network based on the up and down regulated proteins in response to the 
hypercholesterolemic and F. deltoidea treatments. This was the top scoring network with the displayed nodes 
(proteins) associated directly (solid lines) or indirectly (dashed lines)
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VALIDATION BY WESTERN IMMUNOBLOTTING
Consecutively to validate the differentially expressed 
proteins detected by the proteomics analysis, Western 
blotting of HP (MW   11 kDa) and RBP4 (MW   20 kDa) 
were performed. The protein quantification of HP and 
RBP4 were randomly selected respectively from two 
different functional groups for Western blot validation. 
Other proteins were not validated due to scarcity of 
the serum samples. Pooled normal serums (Lane A) 
were used as the control sample. Protein expression 
~~ ~~
levels of both HP and RBP4 were increased abundantly 
in hypercholesterolemic-induced rats. Following 
Atorvastatin and F. deltoidea extract treatments, HP 
was further increased, however in contrary, RBP4 was 
decreased. As shown in Figure 5, the alterations of these 
differentially expressed proteins were in agreement with 
2D-GE results, which implicated the coherency of 2D-
GE result. As reported by Graham et al. (2007), Western 
blot is the ‘gold standard’ assessment for RBP4.
FIGURE 5. Western immunoblot validation for serum levels of HP 
and RBP4 in hypercholesterolemic-induced rats
DISCUSSION
The cholesterol-lowering effect of F. deltoidea on lipid 
profile and proteomic analysis in hypercholesterolemic-
induced rats was evaluated in this study. The outcome 
of lipid profiling included cholesterol (TC), triglyceride 
(TG), high density lipoprotein (HDL) and low density 
lipoprotein (LDL) serum levels showed that F. deltoidea 
extract at lower concentration concomitant with 
cholesterol lowering drug (Atorvastatin) in decreasing 
TC, TG, and LDL levels when compared to the HC group. 
Both HC-E50 and HC-Ato treated group demonstrated 
a normalising effect as the reduced levels of TC, TG 
and LDL were almost nearing the baseline values of 
control rats. Alongside the marked reduction in both TC 
and TG levels, these treatments showed elevated HDL 
cholesterol level (compared to control value) indicating 
the beneficial effects of medicinal plant extract 
administration in preventing or reducing the risk of CVD. 
These observations suggested that F. deltoidea extract 
may influence suppression of cholesterol synthesis, 
thus exaggerate receptor-mediated catabolism of LDL-
cholesterol and increased fecal bile acid secretion in rats 
(Khanna et al. 1996). Contrary in HC-E250 treated group, 
TC, TG and LDL levels were not significantly reduced 
when compared to the HC group. It was discovered that 
lipid levels were not notably improved regardless higher 
dosage of anti-cardiovascular drugs used (Laufs et al. 
2016). This concomitantly to avoid the plausible side 
effect associated with higher doses treatment.
This present study discovered 14 significant 
protein spots that showed differential expressions of 
>1.5 fold. Among the identified differential proteins, we 
are immensely interested in ten proteins (Apo A1, Apo 
E, RBP4, HP, ENPP3, C3, C1s, PROM1, TTR, and PLG), 
which are associated with inflammation and immune 
response, lipid transport and metabolism, cholesterol 
homeostasis, and cholesterol binding. HDL, and LDL 
are major cholesterol carriers in blood plasma. Both 
lipoproteins levels are usually contrary, where a low level 
of HDL and elevated LDL contributes to coronary artery 
disorder (CAD). High level of HDL however, integrally 
demonstrated cardioprotective effect (Heinecke 2009). 
Apo A1 and Apo E are main protein components of HDL 
and LDL, respectively. These apolipoproteins also play 
important roles in cholesterol transport and metabolism. 
In line with this, a decrease in abundance was observed 
for Apo A1 in HC serum proteome in comparison to 
control rats whereas Apo E was elevated.  Treatment 
with F. deltoidea extract caused an increase in Apo A1 and 
reduced Apo E abundancies. These observations reflect 
the lipid profile pattern following HC-E50 and HC-E250 
treatments. Abundance changes in Apo A1 and Apo E 
following treatment with atorvastatin showed an almost 
similar manner as HC-E50, which also in agreement with 
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the lipid profile analysis. This study suggests that the use 
of atorvastatin and F. deltoidea may lead to the elevation 
of serum HDL that consequently will inhibit cholesterol 
build-up and clearance of cholesterol-rich proteins from 
plasma, respectively.
It has been showed that RBP4, the fat mimicking 
adipokines in transporting retinol (Vitamin A) is a potential 
metabolic and cardiovascular biomarker associated 
with hypercholesterolemia (Carbone et al. 2015). Our 
study had experimentally demonstrated an increase 
of RBP4 level in HC rats. This hypercholesterolemia 
event may lead to adipocyte cholesterol overload and 
thus inflammation. Among the metabolic syndromes, 
hypercholesterolemia with non-metabolic disorder like 
obesity or diabetes elucidated the greater affiliation with 
RBP4 (Kim et al. 2011). Post F. deltoidea treatments 
experimentally exhibit normalised RBP4 expression. 
The proteomic outcomes of 2D-GE and Western blotting 
clearly showed corresponding results prior and after F. 
deltoidea treatment, indicating the treatment possess 
cholesterol lowering activity along with remarkable 
impact towards high fat-diet given.
HP is an acute phase protein that helps to bind 
hemoglobin and lower the risk of iron loss, thus, acting 
as an antioxidant. In the previous study, Carbone and 
Montecucco (2015) reported several fold increase of 
plasma HP with systemic inflammatory stimuli on 
infection, malignancy and cardiovascular events. In 
our study, HP in HC group was increased in abundance 
compared to the controlled value. This increment 
could be suggested due to anti-inflammatory and 
antioxidant responses of HP during the progression of 
cardiovascular disease. Treatments of atorvastatin and 
Ficus extracts maintained the same pattern as in HC 
suggesting the corrective effort of the treatments post-
hypercholesterolemic induction.
Significant differences were also observed in 
proteins relevant to inflammation and immune system. 
Both complement components (C3 and C1s) were 
markedly increased in HC rats due to the progression 
of complement activation in atherosclerotic lesions 
beyond the foam cell stage. C3 isolated from 
hypercholesterolemic subjects were apparently enriched 
in HDL and related to innate immunity as well as HDL’s 
cardioprotective effect (Vaisar et al. 2007). Hence, 
many studies concluded the elevated plasma C3 level in 
inflammatory condition is associated with myocardial 
infarction (Muscari et al. 2001), hypertension (Engström 
et al. 2007) and atherosclerosis (Alwaili et al. 2012). 
However, no apparent difference was observed in HC 
rats treated with lipid lowering drug (Atorvastatin). This 
may due to inadequate treatment period (Muscari et al. 
2001) to reduce the elevated C3 levels. In contrary, 
the C3 level in HC-E250 treated HC decreased in 
abundance. This indicates that F. deltoidea extract may 
be involved in non-lipid lowering effects and postulated 
anti- inflammatory mechanisms when higher dosage of F. 
deltoidea extract consumed.
TTR also known as prealbumin is a tetrameric 
structured protein that derives mainly from the liver 
and the choroid plexus of the brain. TTR functions to 
transport protein for thyroxine (T4), triiodothyronine (T3) 
and retinol (Vitamin A) (van Bennekum et al. 2001). TTR 
is an important protein in cholesterol metabolism (Liz et 
al. 2007) and currently a new found inflammation marker 
for CVD (von Zychlinski & Kleffmann 2015). Treatments 
with atorvastatin and low concentration of F. deltoidea 
(HC-E50) significantly increased TTR abundantly when 
compared to HC rats. Intriguingly, TTR is regulated by 
HDL in correspondence of lipid-free Apo A1, and the 
stability of the HDL fragments is not affected by the 
existence or absence of TTR (Sousa et al. 2000).
PLG is another cardiovascular related protein in 
this study, which play crucial role in arterial thrombosis 
(Deitcher & Jaff 2002). PLG and the derived serine 
protease, plasmin, together with the Plasminogen 
Activator Inhibitors (PAI) had postulated to influence 
cardiovascular inflammatory responses mainly in clot 
dissolving properties. This effect also occurred in F. 
deltoidea extracts treatment in which PLG markedly 
downregulated on HC rats. Hence, there are plausible 
thrombolytic effects of F. deltoidea extract in reducing 
the risk of thrombosis in cardiovascular event.  
The molecular and physiological functions of 
PROM1 and ENPP3 remain unclear. In an earlier work 
by Yang et al. (2007) reported that the hyperglycemic 
event in their animal study induced the expression of 
PROM1 in rat’s skeletal muscle by raising glyceraldehyde 
3- phosphate dehydrogenase (GADPH) enzyme which 
further attached to the LDLs in  the blood, forming the 
atheromatous or sticky plaques. In our present study, 
PROM1 in HC group was slightly increased in abundance. 
Upon treatments with atorvastatin and F. deltoidea 
extracts, it could be observed that PROM1 was reduced. 
ENPP3 is localised in apical plasma membrane and 
also in vascular smooth muscle. This ENPP hydrolysed 
the phosphodiester bonds in phospholipids compound. 
However, as summarised from the Ingenuity Pathway 
Analysis (IPA), the biological functions of ENPP3 mainly 
occur in inflammations.
Subjecting the putative proteins to the IPA analysis; 
Apo A1, Apo E, RBP4, HP, ENPP3, C3, C1s, PROM1, 
TTR and PLG were predicted to contribute to the top 
biological function network on ‘Lipid Metabolism, 
Molecular Transport, Small Molecule Biochemistry’ 
with the most significant canonical pathway analysis 
in acute phase response signaling. This further support 
the speculation on acute phase protein molecular 
involvement in anti-inflammatory effects of F. deltoidea. 
However, the network enormously identified Apo A1 
and Apo E involvements in lipid synthesis and clearance 
in cell. These two proteins also demonstrated direct 
interaction with HDL in the network.
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CONCLUSION
In conclusion, this study had demonstrated the 
suppression of hypercholesterolemia following F. 
deltoidea treatment with differential expression 
of serum proteins involved in lipid metabolism and 
transport, inflammation and immune response, anti-
oxidant protein, acute phase protein, cholesterol 
homeostasis, fatty acid catabolism, and cholesterol 
binding. These hypercholesterolemic related proteins 
(Apo A1, Apo E, RBP4, HP, PDE1, C3, C1s, PROM1, 
TTR, and PLG) are the key proteins responsible for the 
suppression of hypercholesterolemia following treatment 
with F. deltoidea. The variations of these proteins 
may provide valuable new molecular insights into the 
mechanism of cholesterol lowering effect of F. deltoidea. 
Thus, further development of this study will enable the 
finding of alternative treatments as well as preventions 
for CVD.
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